Optimus Holding Ltd. is a Swiss Group based in Geneva, founded by Etienne Jornod together with long-standing Swiss entrepreneurs and Abdi Ibrahim (28.5%), a pharmaceutical company operating in 12 countries and exporting to 60 countries worldwide, as a strategic partner. Optimus Holding is fully committed to the sustainable growth of OM Pharma and to invest a triple digit million amount to create a highly attractive global biotechnology company focused on improving the lives of patients with respiratory and inflammatory diseases. They also have a strong desire to further strengthen the Swiss footprint of OM Pharma by investing into people, increasing the employee base, stepping-up manufacturing and deepen research and development activities in Switzerland. OM Pharma is a Geneva-based Biotech company and a leader in the prevention of recurrent respiratory and urinary tract infections. It is also active in the treatment of vascular diseases. It operates worldwide through a strong network of international partners and continues to invest into R&D to develop immunotherapeutic products addressing acute and chronic immunological disorders resulting from infections and inflammation.
View Top Employees from Optimus HoldingWebsite | https://www.ompharma.com/ |
Revenue | $155.3 million |
Employees | View employees |
Founded | 2020 |
Phone | +41 22 783 11 11 |
Technologies |
JavaScript,
HTML,
jQuery
+18 more
(view full list)
|
Industry | Biotechnology, Drug Stores & Pharmacies, Drug Discovery, Retail, Pharmaceuticals |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Optimus Holding employee's phone or email?
The Optimus Holding annual revenue was $155.3 million in 2024.
Optimus Holding is based in Geneva, Geneva.
The NAICS codes for Optimus Holding are [32, 32541, 3254, 325].
The SIC codes for Optimus Holding are [28, 283].